• 1
    Donaldson JS, Yordy K, Lohr KN, Vanselow NA. Primary Care; America's Health in a New Era. Washington, DC: National Academy Press, 1996.
  • 2
    Shehata Y, Ross M, Sheikh A. Undergraduate allergy teaching in a UK medical school: comparison of the described and delivered curriculum. Prim Care Respir J 2007;16:1621.
  • 3
    Warner JO, Lloyd K. Shared learning for chronic conditions: a methodology for developing the Royal College of Paediatrics and Child Health (RCPCH) care pathways for children with allergies. Arch Dis Child 2011;96:15.
  • 4
    Agache I, Ryan D, Rodriguez MR, Yusuf O, Angier E, Jutel M. Allergy management in primary care across European countries - actual status. Allergy 2013;68:836843.
  • 5
    Ryan D, Levy M, Morris A, Sheikh A, Walker S. Management of allergic problems in primary care: time for a rethink? Prim Care Respir J 2005;14:195203.
  • 6
    Jones R, Bartholomew J. General practitioners with special clinical interests: a cross-sectional survey. Br J Gen Pract 2002;52:833834.
  • 7
    Levy ML, Walker S, Woods A, Sheikh A. Service evaluation of a UK primary care-based allergy clinic: quality improvement report. Prim Care Respir J 2009;18:313319.
  • 8
    Ryan D, van Weel C, Bousquet J, Toskala E, Ahlstedt S, Palkonen S et al. Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy 2008;63:981989.
  • 9
    Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2012;67:1824.
  • 10
    Tuomilehto J, Geboers J, Salonen JT, Nissinen A, Kuulasmaa K, Puska P. Decline in cardiovascular mortality in North Karelia and other parts of Finland. Br Med J (Clin Res Ed) 1986;293:10681071.
  • 11
    Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006;61:663670.
  • 12
    Kinnula VL, Vasankari T, Kontula E, Sovijarvi A, Saynajakangas O, Pietinalho A. The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J 2011;20:178183.
  • 13
    Haahtela T, von Hertzen L, Mäkelä M. Hannuksela M; Allergy Programme Working Group. Finnish Allergy Programme 2008–2018-time to act and change the course. Allergy 2008;63:634645.
  • 14
    Centanni S, Di Marco F, Castagna F, Boveri B, Casanova F, Piazzini A. Psychological issues in the treatment of asthmatic patients. Respir Med 2000;94:742749.
  • 15
    Hashiro M, Okumura M. The relationship between the psychological and immunological state in patients with atopic dermatitis. Dermatol Sci 1998;16:231235.
  • 16
    Timonen M, Jokelainen J, Hakko H, Silvennoinen-Kassinen S, Meyer-Rochow VB, Herva A et al. Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry 2003;8:738744.
  • 17
    Goodwin RD. Self-reported hay fever and panic attacks in the community. Ann Allergy Asthma Immunol 2002;88:556559.
  • 18
    Cuffel B, Wamboldt M, Borish L, Kennedy S, Crystal-Peters J. Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics 1999;40:491496.
  • 19
    Evans P, Hucklebridge F, Clow A. Mind, Immunity and Health: The Science of Psychoneuroimmunology. London: F.A. Books, 2000.
  • 20
    Gilmore TM, Alexander BH, Mueller BA, Rivara FP. Occupational injuries and medication use. Am J Ind Med 1996;30:234239.
  • 21
    Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007;120:381387.
  • 22
    Davis E, Nicolas C, Waters E, Cook K, Gibbs L, Gosch A et al. Parent-proxy and child self-reported health-related quality of life: using qualitative methods to explain the discordance. Qual Life Res 2007;16:863871.
  • 23
    Sicherer SH, Noone SA, Muñoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 2001;87:461464.
  • 24
    Lieberman JA, Weiss C, Furlong TJ, Sicherer M, Sicherer SH. Bullying among pediatric patients with food allergy. Ann Allergy Asthma Immunol 2010;105:282286.
  • 25
    Celik G, Mungan D, Abadoğlu O, Pinar NM, Misirligil Z. Direct cost assessments in subjects with seasonal allergic rhinitis living in Ankara, Turkey. Allergy Asthma Proc 2004;25:107113.
  • 26
    Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003;21:116122.
  • 27
    Bousquet J, Demarteau N, Mullol J. van den Akker-van Marle ME, Van Ganse E, Bachert C; XPERT study group. Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 2005;60:788794.
  • 28
    Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469478.
  • 29
    van den Akker-van Marle ME, Bruil J, Detmar SB. Evaluation of cost of disease: assessing the burden to society of asthma in children in the European Union. Allergy 2005;60:140149.
  • 30
    Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 2006;141:189198.
  • 31
    Beyhun NE, Cilingiroğlu N, Sekerel BE. The cost of childhood asthma and its determinants in Ankara. Turk J Pediatr 2007;49:179188.
  • 32
    Jansson SA, Rönmark E, Forsberg B, Löfgren C, Lindberg A, Lundbäck B. The economic consequences of asthma among adults in Sweden. Respir Med 2007;101:22632270.
  • 33
    Colice G, Wu EQ, Birnbaum H, Daher M, Marynchenko MB, Varghese S. Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population. J Occup Environ Med 2006;48:794802.
  • 34
    Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005;35:282287.
  • 35
    Kauppi P, Salo P, Hakola R, Pentti J, Oksanen T, Kivimäki M et al. Allergic rhinitis alone or with asthma is associated with an increased risk of sickness absences. Respir Med 2010;104:16541658.
  • 36
    Witt CM, Brinkhaus B, Pach D, Reinhold T, Wruck K, Roll S et al. Homoeopathic versus conventional therapy for atopic eczema in children: medical and economic results. Dermatology 2009;219:329340.
  • 37
    Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008;25:16.
  • 38
    Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F et al. The direct and indirect cost burden of atopic dermatitis: an employer-payer perspective. Manag Care Interface 2007;20:2632.
  • 39
    Barbeau M, Bpharm HL. Burden of Atopic dermatitis in Canada. Int J Dermatol 2006;45:3136.
  • 40
    Ehlken B, Möhrenschlager M, Kugland B, Berger K, Quednau K, Ring J. Cost-of-illness study in patients suffering from atopic eczema in Germany. Hautarzt 2005;56:11441151.
  • 41
    Jenner N, Campbell J, Marks R. Morbidity and cost of atopic eczema in Australia. Australas J Dermatol 2004;45:1622.
  • 42
    Kemp AS. Cost of illness of atopic dermatitis in children: a societal perspective. Pharmacoeconomics 2003;21:105113.
  • 43
    Verboom P, Hakkaart-Van L, Sturkenboom M, De Zeeuw R, Menke H, Rutten F. The cost of atopic dermatitis in the Netherlands: an international comparison. Br J Dermatol 2002;147:716724.
  • 44
    Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002;46:361370.
  • 45
    Suh DC, Sung J, Gause D, Raut M, Huang J, Choi IS. Economic burden of atopic manifestations in patients with atopic dermatitis–analysis of administrative claims. J Manag Care Pharm 2007;13:778789.
  • 46
    Fox M, Voordouw J, Mugford M, Cornelisse J, Antonides G, Frewer L. Social and economic costs of food allergies in Europe: development of a questionnaire to measure costs and health utility. Health Serv Res 2009;44:16621678.
  • 47
    Flabbee J, Petit N, Jay N, Guénard L, Codreanu F, Mazeyrat R et al. The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network. Allergy 2008;63:360365.
  • 48
    Sladkevicius E, Guest JF. Budget impact of managing cow milk allergy in the Netherlands. J Med Econ 2010;13:273283.
  • 49
    Sladkevicius E, Nagy E, Lack G, Guest JF. Resource implications and budget impact of managing cow milk allergy in the UK. J Med Econ 2010;13:119128.
  • 50
    Zethraeus N, Petersson CJ, Dozzi M, Borres MP, Vignati G, Fiocchi A. Health-care cost reduction resulting from primary-care allergy testing in children in Italy. Ital J Pediatr 2010;36:61.
  • 51
    Food allergy in children and young people. Costing report. NICE clinical guideline 116. 2011.
  • 52
    Food allergy in children and young people. Diagnosis and assessment of food allergy in children and young people in primary care and community settings. NICE clinical guideline 116. 2011.
  • 53
    Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004;34:520526.